Mattiello Veneranda, Sizonenko Stéphane, Baleydier Fréderic, Bernard Fanette, Diezi Manuel, Renella Raffaele
Service de pédiatrie générale, Département de l'enfant et de l'adolescent, HUG, 1211 Genève 14.
Service de développement et de croissance, Département de l'enfant et de l'adolescent, HUG, 1211 Genève 14.
Rev Med Suisse. 2019 Feb 13;15(638):376-381.
Non anemic iron deficiency (NAID) is the most common nutritional deficiency. Symptoms more frequently observed in children and adolescents include fatigue, delayed psychomotor development as well as decreased school and athletic performances. Iron treatment is effective in improving symptoms in older children and adolescents. In children under 2 years of age, there is currently no evidence of the efficacy of substitution therapy on development. Preemptive treatment is not justified considering the available evidence beyond premature or small newborns for gestational age and should only be initiated if a diagnosis of iron deficiency is confirmed. Oral iron supplementation is the first-line treatment of NAID.
非贫血性缺铁(NAID)是最常见的营养缺乏症。在儿童和青少年中更常观察到的症状包括疲劳、精神运动发育迟缓以及学业和运动表现下降。铁剂治疗对改善大龄儿童和青少年的症状有效。在2岁以下儿童中,目前没有证据表明替代疗法对发育有效。考虑到除早产或小于胎龄新生儿外的现有证据,预防性治疗没有依据,只有在确诊缺铁时才应开始治疗。口服铁剂补充是NAID的一线治疗方法。